Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction

Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction

Background: Data regarding the characterization and outcomes of diabetics with heart failure with a mildly reduced ejection fraction (HFmrEF) is scarce. This study investigates the prevalence and prognostic impact of type 2 diabetes in patients with HFmrEF. Methods: Consecutive patients with HFmrEF...

Full description

Bibliographic Details
Main Authors:	Tobias Schupp, Mohammad Abumayyaleh, Kathrin Weidner, Felix Lau, Marielen Reinhardt, Noah Abel, Alexander Schmitt, Jan Forner, Niklas Ayasse, Thomas Bertsch, Muharrem Akin, Ibrahim Akin, Michael Behnes
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Journal of Clinical Medicine
Subjects:	heart failure with mildly reduced ejection fraction HFmrEF diabetes mellitus mortality
Online Access:	https://www.mdpi.com/2077-0383/13/3/742

Similar Items

Prognostic Implications of Septal Hypertrophy in Patients with Heart Failure with Mildly Reduced Ejection Fraction
by: Noah Abel, et al.
Published: (2024-01-01)

Diagnostic and Prognostic Value of Aminoterminal Prohormone of Brain Natriuretic Peptide in Heart Failure with Mildly Reduced Ejection Fraction Stratified by the Degree of Renal Dysfunction
by: Tobias Schupp, et al.
Published: (2024-01-01)

Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction
by: Pengchao Tian, et al.
Published: (2023-06-01)

Impact of atrial fibrillation on cerebro‐cardiovascular outcome of heart failure with mildly‐reduced ejection fraction
by: Na Li, et al.
Published: (2023-10-01)

Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP‐HF registry
by: Matteo Pagnesi, et al.
Published: (2024-02-01)

Comparison of Patients with Reduced and Mildly Reduced Left Ventricular Ejection Fraction: Intermediate Data from the FAR NHL Registry
by: Alžběta Trčková, et al.
Published: (2022-10-01)

The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction
by: Anita Pintér, et al.
Published: (2022-02-01)

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies
by: You Deng, et al.
Published: (2024-01-01)

Impact of signs and symptoms on the prognosis of patients with HFmrEF
by: Zhican Liu, et al.
Published: (2023-08-01)

D‐dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes
by: Liyan Huang, et al.
Published: (2022-10-01)

Heart failure: an update from the last years and a look at the near future
by: Mauro Riccardi, et al.
Published: (2022-12-01)

Impact of sodium glucose co-transporter-2 inhibitors on left atrial functions in patients with type-2 diabetes and heart failure with mildly reduced ejection fraction
by: Shaimaa B. El-Saied, et al.
Published: (2024-02-01)

Risk factors of short‐term, intermediate‐term, and long‐term cardiac events in patients hospitalized for HFmrEF
by: Yunlong Zhu, et al.
Published: (2022-10-01)

Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysis
by: Yintang Wang, et al.
Published: (2022-12-01)

Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
by: Elke Boxhammer, et al.
Published: (2023-04-01)

Obesity increases cardiovascular mortality in patients with HFmrEF
by: Zhican Liu, et al.
Published: (2022-09-01)

Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study
by: Robert Uzel, et al.
Published: (2023-04-01)

Cardio–renal–metabolic syndrome: clinical features and dapagliflozin eligibility in a real‐world heart failure cohort
by: Monika Beles, et al.
Published: (2023-08-01)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
by: Dan Liu, et al.
Published: (2023-04-01)

Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments
by: Matthias Naegele, et al.
Published: (2016-02-01)

Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction
by: Remo H.M. Furtado, et al.
Published: (2023-02-01)

Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest
by: Alberto Palazzuoli, et al.
Published: (2023-01-01)

Factors Associated With Maintenance of an Improved Ejection Fraction: An Echocardiogram‐Based Registry Study
by: Brenna McElderry, et al.
Published: (2023-11-01)

Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
by: Tobias Schupp, et al.
Published: (2022-03-01)

Combined Neuro-Humoral Modulation and Outcomes in Patients with Chronic Heart Failure and Mildly Reduced or Preserved Ejection Fraction
by: Mauro Gori, et al.
Published: (2022-11-01)

Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
by: Ming-Shyan Lin, et al.
Published: (2023-05-01)

Update on the Value of Lung Ultrasound Examination in Acute Decompensated Heart Failure Patients with Various Left Ventricular Ejection Fraction
by: Hui Zhang, et al.
Published: (2022-10-01)

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
by: Timea Magdolna Szabo, et al.
Published: (2023-03-01)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
by: Thomas M. Gorter, et al.
Published: (2023-05-01)

Safety and Long-Term Outcomes of Rotablation in Patients with Reduced (<50%) Left Ventricular Ejection Fraction (rEF) (The Rota-REF Study)
by: Mohamed Ayoub, et al.
Published: (2023-08-01)

Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction
by: Chaofeng Chen, et al.
Published: (2023-02-01)

Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid‐range ejection fraction
by: Dan‐Ying Lee, et al.
Published: (2023-02-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
by: Tobias Schupp, et al.
Published: (2022-08-01)

Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
by: Ibrahim Akin, et al.
Published: (2022-05-01)

Cost‐utility analysis of add‐on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction
by: Yi Tang, et al.
Published: (2023-08-01)

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes
by: Mayu Tochiya, et al.
Published: (2023-04-01)

Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
by: Timea Magdolna Szabo, et al.
Published: (2023-10-01)

Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder
by: Rahul N. Patel, et al.
Published: (2023-12-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)